Sinopharm
1099.HK
#2296
Rank
โ‚น770.62 B
Marketcap
โ‚น246.94
Share price
-0.09%
Change (1 day)
16.67%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: โ‚น209.72 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.09 Billion. In 2024 the company made an earning of โ‚น209.72 Billion a decrease over its 2023 earnings that were of โ‚น290.72 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024โ‚น209.72 B-27.86%
2023โ‚น290.72 B-0.73%
2022โ‚น292.86 B-1.72%
2021โ‚น297.97 B11.7%
2020โ‚น266.76 B18.44%
2019โ‚น225.22 B10.85%
2018โ‚น203.18 B3.05%
2017โ‚น197.17 B36.48%
2016โ‚น144.47 B7.11%
2015โ‚น134.88 B12.38%
2014โ‚น120.02 B25.05%
2013โ‚น95.98 B22.54%
2012โ‚น78.33 B35.43%
2011โ‚น57.83 B52.24%
2010โ‚น37.99 B30.99%
2009โ‚น29.00 B60.59%
2008โ‚น18.05 B48.29%
2007โ‚น12.17 B123.29%
2006โ‚น5.45 B